We report high-throughput profiling of TRIM25 binding sites in triple negative breast cancer cells. Overall design: ChIP-seq was performed using a TRIM25 antibody on 2 triple negative breast cancer ce
T cell antigen-receptor (TCR) and cytokine receptor engagement trigger large changes in Serine/Threonine kinase signalling networks to drive T cell activation and differentiation. The role of only few
BackgroundAlthough notable therapeutic and prognostic benefits of compound kushen injection (CKI) have been found when it was used alone or in combination with chemotherapy or radiotherapy for triple-
